In contrast, the IFNγ-inducing factor IL-18 [50]—having been shown to play a role in both MS [58] and EAE [59, 60] and to contribute to IFNγ-induction in Th1 cells [50, 61]—was only used in some Th1 differentiation protocols. Here, IL18 is linked to myeloid sarcoma.